Product Information
PITAVASTATIN 4 MG TABLET is a generic product labeled by Zydus Pharmaceuticals (USA) Inc., priced at $1.2721 per EA under NDC 68382048316. Its NADAC has been published 123 times since Feb 21, 2024.
Strength
4 mg/1
Manufacturer
Zydus Pharmaceuticals (USA) Inc.NDC
68382048316
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PITAVASTATIN CALCIUMApproval Type
Generic (ANDA)
FDA Application
ANDA206047On Market Since
11/2/2023
Pharmacological Classes
Price Statistics
The NADAC for PITAVASTATIN 4 MG TABLET has been published 123 times since Feb 21, 2024, and over the history we have for it it has declined 45.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2721 per EA |
|---|---|
| All-time high | $2.3451 (Mar 13, 2024) |
| All-time low | $1.2721 (Jun 17, 2026) |
| 52-week high | $1.5488 |
| 52-week low | $1.2721 |
| Median price | $1.5951 |
| Average price | $1.6430 |
| Largest weekly change | +24.9% (Aug 21, 2024) |
| Weeks tracked | 123 |
| Tracking since | Feb 21, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the pitavastatin calcium market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of PITAVASTATIN 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PITAVASTATIN 4 MG TABLET, manufactured by Zydus Pharmaceuticals (USA) Inc., is $1.2721 per EA (NDC 68382048316), effective Jun 24, 2026.
How has the price of PITAVASTATIN 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for PITAVASTATIN 4 MG TABLET has declined 45.8%. It has been tracked across 123 weekly CMS publications since Feb 21, 2024.
What are the highest and lowest recorded NADAC prices for PITAVASTATIN 4 MG TABLET?
Since Feb 21, 2024, the NADAC for PITAVASTATIN 4 MG TABLET has ranged from a low of $1.2721 (Jun 17, 2026) to a high of $2.3451 (Mar 13, 2024), with a median of $1.5951 per EA.
Are there cheaper alternatives to PITAVASTATIN 4 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of PITAVASTATIN 4 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures PITAVASTATIN 4 MG TABLET?
PITAVASTATIN 4 MG TABLET (NDC 68382048316) is labeled by Zydus Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification